The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation.
about
The Herbal Drug Melampyrum pratense L. (Koch): Isolation and Identification of Its Bioactive Compounds Targeting Mediators of InflammationTranscription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) GeneDisruptive environmental chemicals and cellular mechanisms that confer resistance to cell deathThe potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signallingAtheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDLPositive feedback-loop of telomerase reverse transcriptase and 15-lipoxygenase-2 promotes pulmonary hypertensionInhibition of telomerase activity alters tight junction protein expression and induces transendothelial migration of HIV-1-infected cells.PPARalpha: energy combustion, hypolipidemia, inflammation and cancerAdipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Chronic sleep fragmentation induces endothelial dysfunction and structural vascular changes in mice.MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migrationFunctional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.Role for telomerase in pulmonary hypertensionTelomerase Inhibition by Everolimus Suppresses Smooth Muscle Cell Proliferation and Neointima Formation Through Epigenetic Gene SilencingPPARs as therapeutic targets in cardiovascular disease.Human telomerase expression regulation.Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis.An integrated approach for the mechanisms responsible for atherosclerotic plaque regressionDifferential Regulation of Telomerase Reverse Transcriptase Promoter Activation and Protein Degradation by Histone Deacetylase Inhibition.Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair.Elucidating potentially significant genomic regions involved in the initiation and progression of undifferentiated pleomorphic sarcoma.Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by inflammatory stimuli in macrophagesPeroxisome Proliferator-Activated Receptor α Plays an Important Role in the Expression of Monocyte Chemoattractant Protein-1 and Neointimal Hyperplasia after Vascular Injury.Brain lipid-binding protein promotes proliferation and modulates cell cycle in C6 rat glioma cells.Pathways of proliferation: new targets to inhibit the growth of vascular smooth muscle cells.Telmisartan modulates mitochondrial function in vascular smooth muscle cells.Transcriptomic analysis of chicken Myozenin 3 regulation reveals its potential role in cell proliferation.Effect of berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV.Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
P2860
Q21285073-534260A7-810D-4ABA-9E53-9BF5A565CD90Q26739925-0449AF22-7D0E-4EE2-BE6F-6998C6B9DB12Q28080874-65A83286-1840-4F3C-90C1-61D99DDEA7C5Q28087571-6ED61C62-6607-4CBA-9D7C-048B1BE95C0CQ28538861-CC0C8B73-49DB-4D15-ABE4-98083641D9C2Q28581184-42FC32F1-E990-44EA-B7E1-27B989DE2F3CQ33784426-C0C0C1D8-20B1-46AD-B242-CB5BDF08B03AQ33805104-971926FC-5E4D-4B6F-8072-B5B76D83B3BEQ34002877-F8684D16-2CB6-4988-9991-91D07A37B632Q34333926-631488B3-A541-4B78-974D-47A1B48F0311Q34426103-EF7FDD1E-AF03-449C-B0EA-2AE814794C88Q36190972-4BF72A16-E38C-48C8-8AA4-D635B302D7F0Q36582898-5DBA0B2A-4795-47A8-B865-B981C486068AQ36776314-1D6DD411-6143-4D47-8A9E-0D992FE2D159Q36830744-9FC451A6-B7D2-4583-B417-06457EECF633Q37790384-7154CB16-157D-4F74-A28C-7989118668F5Q37905799-9911EC21-8ABE-4702-96A2-0F735350187AQ38343572-EFD442FB-FEB2-49DB-AC91-823E083ABFEDQ38963714-DE418810-4AFE-4803-B6DD-850D949D73FAQ40388317-6F4F798F-CEE8-43D0-A3FD-59AAA1D89FE2Q41719677-0E733A0D-4E16-4528-B955-DEE3FA32F7E4Q41812023-DD9D3AC4-7E79-4B76-A436-7B9C68E06DC5Q42170737-00620E86-2286-4142-A5EA-0966E1D1E175Q42234473-F26AB95A-36FD-40B3-BED3-D841C4C39B62Q42378296-A0D5D78A-20D1-45A0-8AE3-C6EE19A2ED6AQ42840939-2D9AA4F1-0785-49CA-BA62-972DE34BB383Q46089688-8B5F99EC-89FD-4D6C-B5C9-AC4F22498B16Q47159818-FE89BF96-33FF-48A0-AE1D-1DDE24D98473Q51024129-78045580-B275-4807-8837-E2124CCC7C22Q54416763-1929BFF9-2555-4758-9AAC-3AC3D63B5067
P2860
The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The PPARalpha/p16INK4a pathway ...... pendent telomerase activation.
@en
The PPARalpha/p16INK4a pathway ...... pendent telomerase activation.
@nl
type
label
The PPARalpha/p16INK4a pathway ...... pendent telomerase activation.
@en
The PPARalpha/p16INK4a pathway ...... pendent telomerase activation.
@nl
prefLabel
The PPARalpha/p16INK4a pathway ...... pendent telomerase activation.
@en
The PPARalpha/p16INK4a pathway ...... pendent telomerase activation.
@nl
P2093
P2860
P1433
P1476
The PPARalpha/p16INK4a pathway ...... pendent telomerase activation.
@en
P2093
Dennis Bruemmer
Elizabeth B Heywood
Florence Gizard
Hannes M Findeisen
Karrie L Jones
Takashi Nomiyama
P2860
P304
P356
10.1161/CIRCRESAHA.108.186205
P50
P577
2008-09-25T00:00:00Z